At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 24 enrolled
Drug / intervention
doxycycline monohydrate tablet +1 moredrug
Likely dose
doxycycline monohydrate tablet 100 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open-Label, Two-Treatment, Two-Period, Randomized Cross-Over Study To Assess The Bioequivalence Between Commercial Doxycycline Carragenate And Monohydrate Tablet Formulations In Normal Healthy Male Subjects
In Brief
A Phase 4 clinical trial evaluating doxycycline monohydrate tablet and doxycycline carragenate tablet for Bacterial Infection. Completed, enrolled 24 participants across 1 site.
Detailed Summary
The purpose of this protocol is to study if two different tablet formulations of doxycycline are bioequivalent to each other.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBacterial Infection
CountriesIndia
Collaborators--
Timeline
Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2008
Primary CompletionDec 2008
First PostedJul 2009
TodayJul 2026
First PostedJul 15, 2009
Enrollment StartNov 1, 2008
Primary CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 17.0 years ago
Interventions
doxycycline monohydrate tabletdrug
Tablet, 100 mg, Single dose
doxycycline carragenate tabletdrug
Tablet, 100 mg, Single dose